CompanyGraph
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleLevered free cash flow is $41.99M, above the global median of $16.24M
- FinancialsAltman Z-Score 0.09: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.20BCNY326.50M · vs all stocks (USD)
Revenue (TTM)
638.58MCNY94.70M · vs all stocks (USD)
Profit Margin
-62.62%Beta
0.2390xvs all stocks
52-Week Change
-7.51%vs all stocks
Market Capitalization
2.20BCNY326.50M · vs all stocks (USD)
Enterprise Value
2.55BCNY378.44M · vs all stocks (USD)
Forward P/E
2.82xPrice to Sales (TTM)
3.46xPrice to Book (MRQ)
3.57xEnterprise to Revenue
4.00xEnterprise to EBITDA
175.85xGross Margin
22.44%Profit Margin
-62.62%Operating Margin
-13.31%Return on Assets (TTM)
-3.47%Return on Equity (TTM)
-53.08%Revenue (TTM)
638.58MCNY94.70M · vs all stocks (USD)
Revenue per Share (TTM)
1.84CNYUpdated Aug 18, 2026Quarterly Revenue Growth
9.80%Gross Profit (TTM)
134.38MCNY19.93M · vs all stocks (USD)
EBITDA (TTM)
67.64MCNY10.03M · vs all stocks (USD)
Net Income (TTM)
-399.87MCNY-59.30M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-7.65%Operating Cash Flow (TTM)
93.79MCNY13.91M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
283.12MCNY41.99M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
-26.92MCNYFY2025 · Dec 31, 2025Revenue
623.97MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
458.17MCNYFY2025 · Dec 31, 2025Gross Profit
165.80MCNYFY2025 · Dec 31, 2025Operating Income
-112.08MCNY-16.62M · vs all stocks (USD)
Pre-tax Income
-443.10MCNYFY2025 · Dec 31, 2025Income Tax Expense
-4.16MCNYFY2025 · Dec 31, 2025Net Income
-438.95MCNYFY2025 · Dec 31, 2025EBIT
-391.95MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
67.64MCNYFY2025 · Dec 31, 2025Research & Development
41.91MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
126.03MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
51.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.16CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.16CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
348.31MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
348.31MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-438.95MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
34.45MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-460.87MCNYFY2025 · Dec 31, 2025Free Cash Flow
-491.51MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
267.76MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-438.95MCNYFY2025 · Dec 31, 2025Other Non-cash Items
52.95MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-118.47MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
43.61MCNYFY2025 · Dec 31, 2025Capital Expenditures
-30.64MCNYFY2025 · Dec 31, 2025Net Acquisitions
55.44MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
24.79MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
742.68MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-794.82MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-50.95MCNYFY2025 · Dec 31, 2025Other Financing Charges
-22.35MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-125.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
346.75MSharesUpdated Aug 18, 2026Float Shares
239.66MSharesUpdated Aug 18, 2026% Held by Insiders
32.68%vs all stocks
% Held by Institutions
1.03%vs all stocks
Total Cash (MRQ)
329.05MCNY48.80M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9490CNYUpdated Aug 18, 2026Total Debt (MRQ)
709.93MCNY105.28M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.20xCurrent Ratio (MRQ)
0.6170xBook Value per Share (MRQ)
1.80CNYUpdated Aug 18, 2026Total Assets
2.31BCNY342.94M · vs all stocks (USD)
Total Current Assets
844.49MCNYFY2025 · Dec 31, 2025Total Liabilities
1.69BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.47BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
299.34MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.39BCNYFY2025 · Dec 31, 2025Cash
267.75MCNYFY2025 · Dec 31, 2025Cash Equivalents
10.74MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
278.49MCNYFY2025 · Dec 31, 2025Accounts Receivable
209.40MCNYFY2025 · Dec 31, 2025Inventory
257.65MCNYFY2025 · Dec 31, 2025Accounts Payable
182.36MCNYFY2025 · Dec 31, 2025Short-term Debt
1.09BCNYFY2025 · Dec 31, 2025Other Current Liabilities
6.99MCNYFY2025 · Dec 31, 2025Long-term Debt
210.29MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
110.00KCNYFY2025 · Dec 31, 2025Common Stock (Book)
346.75MCNYFY2025 · Dec 31, 2025Retained Earnings
-197.10MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
626.85MCNY92.96M · vs all stocks (USD)
Treasury Stock
9.89MCNYFY2025 · Dec 31, 202552-Week Low
5.00CNYUpdated Aug 18, 202652-Week High
10.42CNYUpdated Aug 18, 202652-Week Change
-7.51%vs all stocks
Beta
0.2390xvs all stocks
50-Day MA
5.81CNYUpdated Aug 18, 2026200-Day MA
7.14CNYUpdated Aug 18, 2026Avg 10-Day Volume
7.80MSharesUpdated Aug 18, 2026Avg 30-Day Volume
8.62MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
-1.15CNYUpdated Aug 18, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.09: distress zoneCritical
Altman Z-Score: 0.09
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Levered free cash flow is $41.99M, above the global median of $16.24MNotable
Levered free cash flow (USD): 41,987,260.726Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Lyell Immunopharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Cuorips Inc.
Tier 1ProductionApproval-Gated PipelineRule
Vanda Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Newron Pharmaceuticals SpA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Inhibikase Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Golden Throat Holdings Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanxi C&Y Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tellgen Corporation
Tier 1ProductionApproval-Gated PipelineRule
Dishman Carbogen Amcis Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
China High-Speed Railway Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone
CommScope Holding Company, Inc.
1 interpretationWithin or Near the Altman Distress Zone
Suzhou Victory Precision Manufacturing Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone